HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Improvement of acquired pendular nystagmus by gabapentin: case report.

Abstract
Acquired Pendular Nystagmus (APN) may cause distressing visual symptoms in patients who are already suffering a severe general disease. Averbuch-Heller et al. conducted the first double-blind controlled study on treatment for APN. They showed that gabapentin substantially reduces pendular nystagmus and significantly increases visual acuity in the majority of patients. We present a patient with APN due to multiple sclerosis who suffered severe oscillopsy and reduction of visual acuity and who substantially benefited from a trial treatment with this agent.
AuthorsK Fabre, H Smet-Dieleman, T Zeyen
JournalBulletin de la Société belge d'ophtalmologie (Bull Soc Belge Ophtalmol) Issue 282 Pg. 43-6 ( 2001) ISSN: 0081-0746 [Print] Belgium
PMID12455139 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Acetates
  • Amines
  • Cyclohexanecarboxylic Acids
  • gamma-Aminobutyric Acid
  • gabapentin
  • Baclofen
Topics
  • Acetates (therapeutic use)
  • Administration, Oral
  • Amines
  • Baclofen (administration & dosage)
  • Cyclohexanecarboxylic Acids
  • Female
  • Humans
  • Middle Aged
  • Multiple Sclerosis (complications)
  • Nystagmus, Pathologic (drug therapy, etiology)
  • Treatment Outcome
  • gamma-Aminobutyric Acid

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: